These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37312040)

  • 1. Tamoxifen decreases ovarian toxicity without compromising cancer treatment in a rat model of mammary cancer.
    Nynca A; Swigonska S; Ruszkowska M; Sadowska A; Orlowska K; Molcan T; Myszczynski K; Otrocka-Domagala I; Paździor-Czapula K; Kurowicka B; Petroff BK; Ciereszko RE
    BMC Genomics; 2023 Jun; 24(1):325. PubMed ID: 37312040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Action of Tamoxifen in the Ovaries of Rats with Mammary Neoplasia.
    Nynca A; Swigonska S; Molcan T; Petroff BK; Ciereszko RE
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries.
    Piasecka-Srader J; Blanco FF; Delman DH; Dixon DA; Geiser JL; Ciereszko RE; Petroff BK
    Biol Reprod; 2015 May; 92(5):132. PubMed ID: 25833159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and Potential for Ovarian Preservation with SERMs.
    Ting AY; Petroff BK
    Biol Reprod; 2015 May; 92(5):133. PubMed ID: 25810474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the protective mechanisms of tamoxifen in radiotherapy-induced ovarian follicular loss: impact on insulin-like growth factor 1.
    Mahran YF; El-Demerdash E; Nada AS; Ali AA; Abdel-Naim AB
    Endocrinology; 2013 Oct; 154(10):3888-99. PubMed ID: 23798597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.
    Ting AY; Kimler BF; Fabian CJ; Petroff BK
    Cancer Prev Res (Phila); 2008 Dec; 1(7):546-53. PubMed ID: 19139004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat.
    Ting AY; Petroff BK
    J Assist Reprod Genet; 2010 Nov; 27(11):591-7. PubMed ID: 20711751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian status influences the skeletal effects of tamoxifen in adult rats.
    Sibonga JD; Evans GL; Hauck ER; Bell NH; Turner RT
    Breast Cancer Res Treat; 1996; 41(1):71-9. PubMed ID: 8932878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian hyperstimulation closely associated with resumption of follicular growth after chemotherapy during tamoxifen treatment in premenopausal women with breast cancer: a multicenter retrospective cohort study.
    Yamazaki R; Inokuchi M; Ishikawa S; Ayabe T; Jinno H; Iizuka T; Ono M; Myojo S; Uchida S; Matsuzaki T; Tangoku A; Kita M; Sugie T; Fujiwara H
    BMC Cancer; 2020 Jan; 20(1):67. PubMed ID: 31996163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.
    McDougal A; Wormke M; Calvin J; Safe S
    Cancer Res; 2001 May; 61(10):3902-7. PubMed ID: 11358803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial.
    Kim HA; Lee JW; Nam SJ; Park BW; Im SA; Lee ES; Jung YS; Yoon JH; Kang SS; Lee SJ; Park KH; Jeong J; Cho SH; Kim SY; Kim LS; Moon BI; Lee MH; Kim TH; Park C; Jung SH; Gwak G; Kim J; Kang SH; Jin YW; Kim HJ; Han SH; Han W; Hur MH; Noh WC;
    J Clin Oncol; 2020 Feb; 38(5):434-443. PubMed ID: 31518174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
    Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
    Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparisons of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer patients stratified by estrogen receptor and menopausal status.
    Nomura Y; Shirouzu M; Takayama T
    Breast Cancer Res Treat; 1998 May; 49(1):51-60. PubMed ID: 9694611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of mammary gland carcinogenesis by post-initiation treatment of rats with tamoxifen or indole-3-carbinol or their combination.
    Malejka-Giganti D; Parkin DR; Bennett KK; Lu Y; Decker RW; Niehans GA; Bliss RL
    Eur J Cancer Prev; 2007 Apr; 16(2):130-41. PubMed ID: 17297389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of tamoxifen and its 4-hydroxy and N-desmethyl metabolites: activation of caspases and induction of apoptosis in rat mammary tumors and in human breast cancer cell lines.
    Mandlekar S; Hebbar V; Christov K; Kong AN
    Cancer Res; 2000 Dec; 60(23):6601-6. PubMed ID: 11118041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tamoxifen on the Notch signaling pathway in ovarian follicles of mice.
    Zık B; Kurnaz H; Güler S; Asmaz ED
    Biotech Histochem; 2019 Aug; 94(6):410-419. PubMed ID: 31305178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria.
    Perumal SS; Shanthi P; Sachdanandam P
    Chem Biol Interact; 2005 Feb; 152(1):49-58. PubMed ID: 15766922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine disruption by indole-3-carbinol and tamoxifen: blockage of ovulation.
    Gao X; Petroff BK; Oluola O; Georg G; Terranova PF; Rozman KK
    Toxicol Appl Pharmacol; 2002 Sep; 183(3):179-88. PubMed ID: 12383709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.